Europe Pharmaceuticals Native Starch Market was valued at USD 0.5 Billion in 2022 and is projected to reach USD 0.9 Billion by 2030, growing at a CAGR of 7.8% from 2024 to 2030.
The European pharmaceutical industry's demand for native starches has been steadily increasing, reflecting a broader trend toward natural and sustainable excipients in drug formulations. Native starches, derived from sources like corn, wheat, and potatoes, serve as essential components in various pharmaceutical applications due to their biocompatibility and functional properties.
Key Types of Native Starches in Pharmaceuticals:
Corn Starch: Widely used as a disintegrant and filler in tablet formulations, corn starch facilitates the breakdown of tablets in the digestive tract, ensuring proper drug release.
Wheat Starch: Valued for its binding properties, wheat starch is utilized in granulation processes to enhance tablet cohesion and stability.
Potato Starch: Known for its high amylopectin content, potato starch offers excellent viscosity and is employed in capsule formulations and as a thickening agent in liquid pharmaceuticals.
Industry Requirements and Trends:
Purity and Quality: The pharmaceutical sector demands native starches with high purity levels, free from contaminants, to meet stringent regulatory standards and ensure patient safety.
Functional Performance: Starches must exhibit consistent physicochemical properties, such as particle size and moisture content, to ensure uniformity in drug formulations.
Sustainability: With a growing emphasis on eco-friendly practices, pharmaceutical companies are sourcing native starches from sustainable agriculture, aligning with global sustainability goals.
Non-GMO and Allergen-Free Options: The industry is increasingly seeking non-genetically modified and allergen-free starches to cater to sensitive populations and regulatory preferences.
Market Dynamics:
The European native starch market is projected to experience significant growth, driven by the pharmaceutical industry's expanding demand for natural excipients. This trend is complemented by the food and beverage sector's increasing use of native starches as thickeners and stabilizers. The market's growth is further supported by advancements in starch processing technologies, enhancing the functionality and applicability of native starches in various industrial applications.
In my experience working within the pharmaceutical industry, the shift toward natural excipients like native starches has been notable. Companies are actively reformulating products to replace synthetic additives with natural alternatives, responding to both regulatory pressures and consumer preferences for cleaner labels. This transition not only meets compliance requirements but also enhances the marketability of pharmaceutical products in an increasingly health-conscious market.
Furthermore, the integration of native starches aligns with the industry's sustainability initiatives. By sourcing starches from renewable resources and supporting sustainable farming practices, pharmaceutical companies contribute to environmental conservation efforts, which is increasingly becoming a factor in corporate responsibility assessments.
In conclusion, the European pharmaceutical sector's demand for native starches is set to rise, driven by the need for natural, sustainable, and high-quality excipients. This trend presents opportunities for starch producers to innovate and meet the evolving requirements of the pharmaceutical industry, ensuring compliance, functionality, and sustainability in drug development and production processes.
Get an In-Depth Research Analysis of the Europe Pharmaceuticals Native Starch Market Size And Forecast [2025-2032]
Cargill
Tereos
Roquette
Visco Starch
Colorcon
Agrana
Paramesu Biotech
Shandong Liaocheng E Hua Pharmaceutical
SPAC Starch Products (India) Limited
Sanstar Biopolymers Ltd
Ingredion
Shandong Liujia
Universal Starch-Chem Allied Ltd
Hunan Er-Kang Pharmaceutical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Pharmaceuticals Native Starch Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Pharmaceuticals Native Starch Market
Corn Starch
Potato Starch
Wheat Starch
Tapioca Starch
Rice Starch
Binders & Coating Agents
Disintegrants
Fillers & Extenders
Stabilizers
Thickening Agents
Oral Solid Dosage Forms
Liquid Dosage Forms
Topical Formulations
Injectable Drugs
Controlled Release Formulations
Texturizing Agent
Moisture Retention Agent
Bulking Agent
Emulsifying Agent
Film-Forming Agent
Pharmaceutical Manufacturers
Contract Research Organizations (CROs)
Contract Manufacturing Organizations (CMOs)
Research and Development Labs
Academic Institutions
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Pharmaceuticals Native Starch Market Research Analysis
1. Introduction of the Europe Pharmaceuticals Native Starch Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Pharmaceuticals Native Starch Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Pharmaceuticals Native Starch Market, By Type
6. Europe Pharmaceuticals Native Starch Market, By Application
7. Europe Pharmaceuticals Native Starch Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe Pharmaceuticals Native Starch Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/